期刊
MARINE DRUGS
卷 12, 期 7, 页码 4086-4095出版社
MDPI
DOI: 10.3390/md12074086
关键词
deferoxamine; enterovirus 71; hand; foot and mouth disease; B cells
资金
- National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BA139B02]
- National Science and Technology Major Projects of Infectious Disease of China [2012ZX10004501]
- Youth Foundation of CAMS PUMC [3332013041]
Enterovirus 71 is one of the major causative agents of hand, foot and mouth disease in children under six years of age. No vaccine or antiviral therapy is currently available. In this work, we found that the number of B cells was reduced in enterovirus 71-infected mice. Deferoxamine, a marine microbial natural product, compensated for the decreased levels of B cells caused by enterovirus 71 infection. The neutralizing antibody titer was also improved after deferoxamine treatment. Furthermore, deferoxamine relieved symptoms and reduced mortality and muscle damage caused by enterovirus 71 infection. This work suggested that deferoxamine has the potential for further development as a B cell-immunomodulator against enterovirus 71.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据